| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.065 | 0.3 |